Loading institutional data...
Loading institutional data...
Institutional accumulation: ownership increased +0.94% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 1 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $148.40B 100.0% | $996.35B 100.0% | $941.17B 100.0% | $868.69B 100.0% | $853.06B 100.0% | $717.29B 100.0% | $509.71B 100.0% | $376.84B 100.0% | $250.27B 100.0% | $158.27B 100.0% |
| Cost of Revenue | $89.32B 60.2% | $598.28B 60.0% | $586.32B 62.3% | $549.70B 63.3% | $539.45B 63.2% | $421.20B 58.7% | $282.37B 55.4% | $206.93B 54.9% | $107.04B 42.8% | $59.48B 37.6% |
| Research & Development | $9.64B 6.5% | $57.15B 5.7% | $52.26B 5.6% | $56.74B 6.5% | $55.47B 6.5% | $57.24B 8.0% | $43.08B 8.5% | $37.44B 9.9% | $22.75B 9.1% | $17.06B 10.8% |
| Selling, General & Admin | $4.80B 3.2% | $44.24B 4.4% | $41.98B 4.5% | $42.18B 4.9% | $31.92B 3.7% | $55.22B 7.7% | $28.20B 5.5% | $24.89B 6.6% | $16.24B 6.5% | $12.24B 7.7% |
| Operating Income | $7.27B 4.9% | $140.91B 14.1% | $113.35B 12.0% | $100.35B 11.6% | $69.64B 8.2% | $89.68B 12.5% | $91.43B 17.9% | $57.08B 15.1% | $69.31B 27.7% | $48.05B 30.4% |
| Interest Expense | $1.42B 1.0% | $9.60B 1.0% | $7.95B 0.8% | $5.92B 0.7% | $4.91B 0.6% | $4.48B 0.6% | $5.18B 1.0% | $5.19B 1.4% | $3.57B 1.4% | $2.67B 1.7% |
| Other Income (Expense), net | $220.0M 0.1% | $3.39B 0.3% | $6.16B 0.7% | $5.82B 0.7% | $10.52B 1.2% | $7.58B 1.1% | $7.44B 1.5% | $221.0M 0.1% | $4.16B 1.7% | $6.09B 3.8% |
| Pretax Income | $18.76B 12.6% | $155.46B 15.6% | $101.60B 10.8% | $89.19B 10.3% | $59.55B 7.0% | $165.58B 23.1% | $166.65B 32.7% | $96.22B 25.5% | $100.40B 40.1% | $60.03B 37.9% |
| Income Tax Expense | $4.36B 2.9% | $35.45B 3.6% | $22.53B 2.4% | $15.55B 1.8% | $26.82B 3.1% | $29.28B 4.1% | $20.56B 4.0% | $16.55B 4.4% | $18.20B 7.3% | $13.78B 8.7% |
| Net Income | $15.02B 10.1% | $130.11B 13.1% | $80.01B 8.5% | $72.78B 8.4% | $62.25B 7.3% | $150.58B 21.0% | $149.43B 29.3% | $87.89B 23.3% | $64.09B 25.6% | $43.67B 27.6% |
| Per Share | ||||||||||
| EPS (Basic) | $0.83 | $6.89 | $3.95 | $3.46 | $2.87 | $6.95 | $7.10 | $4.24 | $3.13 | $2.19 |
| EPS (Diluted) | $0.80 | $6.70 | $3.91 | $3.43 | $2.84 | $6.84 | $6.99 | $4.17 | $3.06 | $2.12 |
| Weighted Avg Shares (Basic) | 18.57B | 18.79B | 20.18B | 20.98B | 21.56B | 21.62B | 21.02B | 20.64B | 20.43B | 19.94B |
| Weighted Avg Shares (Diluted) | 19.23B | 19.32B | 20.36B | 21.11B | 21.79B | 21.98B | 21.35B | 20.99B | 20.88B | 20.58B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $4.9B dividends + $1.1B buybacks = $6.0B returned.
3 consecutive years of dividend increases · 69%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Modest payoff on reinvested capital. Current ROIC on all capital: 10%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
No current price collected.
Nothing notable to watch.
No material risks flagged.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 54.9 | 55.4 | 58.7 | 63.2 | 63.3 | 62.3 | 60.0 | 60.2 |
| R&D | 9.9 | 8.5 | 8.0 | 6.5 | 6.5 | 5.6 | 5.7 | 6.5 |
| SG&A | 6.6 | 5.5 | 7.7 | 3.7 | 4.9 | 4.5 | 4.4 | 3.2 |
| Operating Income | 15.1 | 17.9 | 12.5 | 8.2 | 11.6 | 12.0 | 14.1 | 4.9 |
| Income Tax | 4.4 | 4.0 | 4.1 | 3.1 | 1.8 | 2.4 | 3.6 | 2.9 |
| Net Income | 23.3 | 29.3 | 21.0 | 7.3 | 8.4 | 8.5 | 13.1 | 10.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BBAAY: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.